Genetic Polymorphisms of CCDC26 rs891835, rs6470745, and rs55705857 in Glioma Risk: A Systematic Review and Meta-analysis
- 138 Downloads
A genetic component is accepted in the etiology of the glioma. Evidence from candidate genes studies and GWAS reveal that CCDC26 gene could increase the risk of glioma. We performed a systematic review and up-to-date meta-analysis to explore if polymorphisms of CCDC26 gene (rs891835, rs6470745, and rs55705857) may be a susceptibility factor in developing glioma. An online search in PubMed, Web of Science, and SCOPUS up to September 2018 was performed. The pooled odds ratios were evaluated by fixed effects model and random effects model. Analyses of the overall sample and ethnic sub-groups were performed. In all the analyses, the allelic, additive, dominant, and recessive models were used. We found an association between all polymorphisms evaluated and an increased risk for glioma in the overall population in all the models studied. In sub-group analysis, we found that rs891835 and rs6470745 increased the risk of glioma in Europeans and Caucasians. On the other hand, the rs891835 polymorphism did not reveal any statistical association in Chinese population. Taken into consideration the limitations of this study, the present findings suggest a possible participation of rs891835, rs6470745, and rs55705857 as risk factors to develop glioma. Furthermore, it is possible that the involvement of CCDC26 variants depends on ethnicity. However, we recommend to perform further studies to have conclusive outcomes.
KeywordsMeta-analysis Glioma CCDC26 Biomarkers
T.B.G.C., C.A.T.Z., and A.D.G.M. performed substantial contributions to conception and design; J.J.M.M., T.B.G.C., and J.M.R.P. participated in acquisition of data, or analysis and interpretation of data; I.E.J.R., M.L.L.N., and N.P.H. drafted the article or revised it critically for important intellectual content; and all the authors gave their final approval of the version to be published.
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Compliance with Ethical Standards
Conflict of interest
The authors declare no conflict of interest.
- Cui T (2015) CCDC26 rs4295627 polymorphism and glioma risk: a meta-analysis. Int J Clin Exp Med 8:3862–3868Google Scholar
- Gonzalez-Castro TB, Hernandez-Diaz Y, Juarez-Rojop IE, Lopez-Narvaez ML, Tovilla-Zarate CA, Genis-Mendoza A, Alpuin-Reyes M (2016) The role of C957T, TaqI and Ser311Cys polymorphisms of the DRD2 gene in schizophrenia: systematic review and meta-analysis. Behav Brain Funct (BBF) 12:29. https://doi.org/10.1186/s12993-016-0114-z CrossRefGoogle Scholar
- Jenkins RB et al (2011) Distinct germ line polymorphisms underlie glioma morphologic heterogeneity. Cancer Genet 204:13–18. https://doi.org/10.1016/j.cancergencyto.2010.10.002 CrossRefGoogle Scholar